FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Congress asks CEOs to pledge truth in DTC

Tools

Dingell and Stupak strike again. Fresh on the heels of their DTC hearing, the two Congressmen have issued letters to four top pharma execs--CEOs at Merck, Pfizer, Schering-Plough, and Johnson & Johnson--asking them to commit to honest-Abe advertising. "Consumers should not have to rely on the oversight function of Congress to make sure drug companies tell the truth in their ad campaigns," Stupak said, calling DTC advertising a "privilege" that comes with responsibility.

The two men also question the industry's own DTC guidelines. In a separate letter to the Pharmaceutical Research and Manufacturers of America, they say that the guidelines should be updated. Among the suggested changes: Ads for drugs with "black box" warnings have to specifically include that cautionary tale.

- check out the House Energy and Commerce Committee's release
- get the article at CNN Money
- see the story in PharmaTimes

Related Articles:
Will DTC hearing lead to new regulation?
Stupak plays bad cop against pharma
DTC hearing has high-powered guest list
To DTC or not to DTC?


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Pfizer   DTC advertising   Merck   John Dingell   Stupak   Bart Stupak